Leap Therapeutics Inc (5MC1) : Analyse, Valorisation, Dividende et Ratios Financiers

Leap Therapeutics Inc

5MC1StockF

€—

5

Leap Therapeutics Inc

€—

5MC1StockF

Arberion© 2026

Arberion

Loading market data